Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 23;1(1):CD004753.
doi: 10.1002/14651858.CD004753.pub4.

Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis

Julie Brown  1 , Tineke J Crawford  1 , Claire Allen  2 , Sally Hopewell  3 , Andrew Prentice  4
Affiliations

Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis

Julie Brown et al. Cochrane Database Syst Rev. .

Abstract

Background: Endometriosis is a common gynaecological condition that affects women and can lead to painful symptoms and infertility. It greatly affects women's quality of life, impacting their careers, everyday activities, sexual and nonsexual relationships and fertility. Nonsteroidal anti-inflammatory drugs (NSAIDs) are most commonly used as first-line treatment for women with pain associated with endometriosis.

Objectives: To assess effects of NSAIDs used for management of pain in women with endometriosis compared with placebo, other NSAIDs, other pain management drugs or no treatment.

Search methods: We searched the Cochrane Gynaecology and Fertility Group Specialised Register of Controlled Trials (October 2016), published in the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, as well as MEDLINE (January 2008 to October 2016), Embase (date limited from 1 January 2016 to 19 October 2016, as all earlier references are included in CENTRAL output as a result of the Embase project), registers of ongoing trials and the reference lists of relevant publications. We identified no new randomised controlled trials. Unless we identify new evidence in the future, we will not update this review.

Selection criteria: We included all randomised controlled trials (RCTs) describing use of NSAIDs for management of pain associated with endometriosis in women of all ages.

Data collection and analysis: In the 2009 update of this review, two review authors (CA and SH) independently read and extracted data from each of the included studies. We analysed cross-over trials using the inverse variance method of RevMan to calculate odds ratios for binary outcomes.

Main results: We identified no new trials for the 2016 update. This review includes two trials, but we included only one trial, with 24 women, in the analysis.The overall risk of bias was unclear owing to lack of methodological detail. Using the GRADE method, we judged the quality of the evidence to be very low. We downgraded evidence for risk of bias and for imprecision (wide confidence intervals and evidence based on a single small trial).Comparison of NSAIDs (naproxen) versus placebo revealed no evidence of a positive effect on pain relief (odds ratio (OR) 3.27, 95% confidence interval (CI) 0.61 to 17.69; one trial, 24 women; very low-quality evidence) in women with endometriosis. Evidence indicating whether women taking NSAIDs (naproxen) were less likely to require additional analgesia (OR 0.12, 95% CI 0.01 to 1.29; one trial, 24 women; very low-quality evidence) or to experience side effects (OR 0.46, 95% CI 0.09 to 2.47; one trial, 24 women; very low-quality evidence) when compared with placebo was inconclusive.Studies provided no data on quality of life, effects on daily activities, absence from work or school, need for more invasive treatment or participant satisfaction with treatment.

Authors' conclusions: Owing to lack of high-quality evidence and lack of reporting of outcomes of interest for this review, we can make no judgement as to whether NSAIDs (naproxen) are effective in managing pain caused by endometriosis. No evidence shows whether any individual NSAID is more effective than another. As shown in other Cochrane reviews, women taking NSAIDs must be aware that these drugs may cause unintended effects.

PubMed Disclaimer

Conflict of interest statement

One review author (CA) has endometriosis and is a member of Endometriosis UK. Another review author (AP) was Chairman of Endometriosis UK at the time the review was originally written. JB, TC and SH have no interests to declare.

Figures

1
1
Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
2
2
Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
1.1
1.1. Analysis
Comparison 1 NSAID versus placebo, Outcome 1 Overall pain relief.
1.2
1.2. Analysis
Comparison 1 NSAID versus placebo, Outcome 2 Unintended effects of treatment.
1.3
1.3. Analysis
Comparison 1 NSAID versus placebo, Outcome 3 Requirements for additional medication.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Kauppila 1979 {published data only}
    1. Kauppila A, Puolakka J, Ylikorkala O. Prostaglandin biosynthesis inhibitors and endometriosis. Prostaglandins 1979;18(4):655‐61. - PubMed
    1. Ylikorkala O, Viinikka L. Postaglandins and endometriosis. Acta Obstetrica et Gynecologica Scandinavica 1983;113 Suppl:105‐7. - PubMed
Kauppila 1985 {published data only}
    1. Kauppila A, Ronnberg L. Naproxen sodium in dysmenorrhoea secondary to endometriosis. Obstetrics and Gynaecology 1985;65(3):379‐83. - PubMed

References to studies excluded from this review

Cobellis 2004 {published data only}
    1. Cobellis L, Razzi S, Simone S, Sartini A, Fave A, Danero S, et al. The treatment with a COX‐2 specific inhibitor is effective in the management of pain related to endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2004;116:100‐2. - PubMed

Additional references

Barbieri 1990
    1. Barbieri RL. Endometriosis 1990 ‐ current treatment approaches. Drugs 1990;39(4):502‐10. - PubMed
Berube 1998
    1. Berube S, Marcoux S, Maheux R, Graves G, Wrixon W, O'Keane J, et al. Characteristics related to the prevalence of minimal or mild endometriosis in infertile women. Epidemiology 1998;9(5):504‐10. - PubMed
Canavan 2000
    1. Canavan TP, Radosh L. Managing endometriosis. Strategies to minimize pain and damage. Postgraduate Medicine 2000;107(3):213‐6, 222‐4. - PubMed
Davies 2003
    1. Davies B. The best practice in treatment. Living with Endometriosis ‐ The Way Forward (oral presentation, London, UK) 2003; Vol. April 30.
Dawood 1986
    1. Dawood MY. Current concepts in the etiology and treatment of primary dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica 1986;138 Suppl:7‐10. - PubMed
Elbourne 2002
    1. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31:140‐9. - PubMed
Hart 1984
    1. Hart FD, Huskisson EC. Non‐steroidal anti‐inflammatory drugs. Current status and rational therapeutic use. Drugs 1984;27(3):232‐55. - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org.
Jones 2002
    1. Jones GL, Kennedy SH, Jenkinson C. Health‐related quality of life measurement in women with common benign gynecologic conditions: a systematic review. American Journal of Obstetrics and Gynecology 2002;187(2):501‐11. - PubMed
Kennedy 2003
    1. Kennedy S. International links. Living with Endometriosis ‐ The Way Forward (oral presentation, London, UK) 2003; Vol. April 30.
Marjoribanks 2015
    1. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD001751.pub3] - DOI - PMC - PubMed
Murphy 2002
    1. Murphy AA. Clinical aspects of endometriosis. Annals of the New York Academy of Sciences 2002;955:1‐10, Discussion 34‐6, 396‐406. - PubMed
Prentice 2003
    1. Prentice A, Deary AJ, Bland E. Progestogens and anti‐progestogens for pain associated with endometriosis (Cochrane Review). Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD002122] - DOI - PubMed
rAFS 1985
    1. Revised American Fertility Society classification of endometriosis. Revised American Fertility Society classification of endometriosis. Fertility and Sterility 1985;43:351‐2. - PubMed
RevMan 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rice 2002
    1. Rice VM. Conventional medical therapies for endometriosis. Annals of the New York Academy of Sciences 2002;955:343‐52, Discussion 389‐93, 396‐406. - PubMed
Vessy 1992
    1. Vessey MP, Villard‐Mackintosh L, Painter R. Epidemiology of endometriosis in women attending family planning clinics. BMJ 1992;306(6871):182‐4. - PMC - PubMed

References to other published versions of this review

Allen 2004
    1. Allen C, Hopewell S, Prentice A. Non‐steroidal anti‐inflammatory drugs for pain in women with endometriosis. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD004753] - DOI - PubMed
Allen 2005
    1. Allen C, Hopewell S, Prentice A, Gregory D. Non‐steroidal anti‐inflammatory drugs for pain in women with endometriosis. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD004753.pub2] - DOI - PubMed
Allen 2009
    1. Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD004753.pub3] - DOI - PubMed

Publication types

Substances